170 related articles for article (PubMed ID: 3539196)
1. Immune response to autologous human melanoma: implication of class I and II MHC products.
Fossati G; Anichini A; Taramelli D; Balsari A; Gambacorti-Passerini C; Kirkwood JM; Parmiani G
Biochim Biophys Acta; 1986 Dec; 865(3):235-51. PubMed ID: 3539196
[No Abstract] [Full Text] [Related]
2. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
3. A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.
Somasundaram R; Swoboda R; Caputo L; Lee A; Jackson N; Marincola FM; Guerry D; Herlyn D
Int J Cancer; 2003 Apr; 104(3):362-8. PubMed ID: 12569560
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). II. Blocking of anti-class I CTL clones by anti-DR MoAb.
Anichini A; Ress S; Strassmann G; Bach FH
Hum Immunol; 1985 Jun; 13(2):139-43. PubMed ID: 2409062
[TBL] [Abstract][Full Text] [Related]
5. Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells.
Parmiani G; Fossati G; Taramelli D; Anichini A; Balsari A; Gambacorti-Passerini C; Sciorelli G; Cascinelli N
Cancer Metastasis Rev; 1985; 4(1):7-26. PubMed ID: 3888384
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of monoclonal mouse cytotoxic T lymphocytes with specificity for HLA-A,B or -DR alloantigens.
Engelhard VH; Benjamin C
J Immunol; 1982 Dec; 129(6):2621-9. PubMed ID: 6982933
[No Abstract] [Full Text] [Related]
7. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
[TBL] [Abstract][Full Text] [Related]
8. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
9. The role of T8 in the cytotoxic activity of cloned cytotoxic T lymphocyte lines specific for class II and class I major histocompatibility complex antigens.
Spits H; Yssel H; Voordouw A; de Vries JE
J Immunol; 1985 Apr; 134(4):2294-8. PubMed ID: 2579137
[TBL] [Abstract][Full Text] [Related]
10. Antigenic profile of human melanoma cells. Analysis with monoclonal antibodies to histocompatibility antigens and to melanoma-associated antigens.
Natali PG; Giacomini P; Russo C; Steinbach G; Fenoglio C; Ferrone S
J Cutan Pathol; 1983 Aug; 10(4):225-37. PubMed ID: 6350388
[No Abstract] [Full Text] [Related]
11. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
Wölfel T; Klehmann E; Müller C; Schütt KH; Meyer zum Büschenfelde KH; Knuth A
J Exp Med; 1989 Sep; 170(3):797-810. PubMed ID: 2788708
[TBL] [Abstract][Full Text] [Related]
12. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
Darrow TL; Slingluff CL; Seigler HF
J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141
[TBL] [Abstract][Full Text] [Related]
13. Modulation of immune lysis of tumor cells by interferon.
Ng AK; Imai K; Pellegrino MA; Vitiello A; Indiveri F; Wilson BS; Ferrone S
Biomembranes; 1983; 11():313-39. PubMed ID: 6187384
[No Abstract] [Full Text] [Related]
14. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte clones detecting novel supertypic HLA class II allospecificities.
Flomenberg N; Knowles RW; Williams D; Horibe K; Rosenkrantz K; Dupont B
Immunogenetics; 1985; 22(3):295-300. PubMed ID: 2412958
[No Abstract] [Full Text] [Related]
16. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
Itoh K; Platsoucas CD; Balch CM
J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710
[TBL] [Abstract][Full Text] [Related]
17. HLA class II-restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma-infiltrating lymphocytes.
Le Dréan E; Gervois N; Diez E; Semana G; Dreno B; Jotereau F
Eur J Immunol; 1995 Oct; 25(10):2732-6. PubMed ID: 7589064
[TBL] [Abstract][Full Text] [Related]
18. Membrane structures involved in auto-tumor recognition.
Vánky F
Biochim Biophys Acta; 1986 Dec; 865(3):253-65. PubMed ID: 3539197
[TBL] [Abstract][Full Text] [Related]
19. Allocytotoxic T cell clones: both Leu 2+3- and Leu 2-3+ T cells recognize class I histocompatibility antigens.
Flomenberg N; Naito K; Duffy E; Knowles RW; Evans RL; Dupont B
Eur J Immunol; 1983 Nov; 13(11):905-11. PubMed ID: 6196208
[TBL] [Abstract][Full Text] [Related]
20. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
